Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

LiCl-driven direct synthesis of mono-protected esters from long-chain dicarboxylic fatty acids

Yulong Kuang*ab, Xiaohui Yangc, Tianhong Qinb, Jigui Wangb, Paul Guob and Chaozhe Jiang*abd
aSouthwest Jiaotong University, West Hightech Zone, Chengdu, Sichuan 611756, People's Republic China. E-mail: kyl16320@163.com; jiangchaozhe@swjtu.edu.cn
bAstaTech (Chengdu) Biopharmaceutical Corporation, 488 Kelin West Road Wenjiang, Chengdu 611130, Sichuan, People's Republic China
cSuining Middle School, 96 Yucai Road, Suining, 629018, Sichuan, People's Republic China
dEngineering Research Center of Railway Industry of Operation Safety Assurance, National Railway Administration of P.R.C., Chengdu, Sichuan 610031, China

Received 11th July 2025 , Accepted 17th September 2025

First published on 7th October 2025


Abstract

A one-step mono-esterification method for long-chain dicarboxylic fatty acids [HO2C(CH2)nCO2H; n ≥ 14] was developed using TFAA (trifluoroacetic anhydride) and LiCl as esterification reagents. This approach was particularly effective for synthesizing mono tert-butyl esters, which are key intermediates in the production of segments of semaglutide and tirzepatide—two blockbuster drugs with their 2024 sales valued in billions of dollars. The addition of LiCl critically enhanced the monoester selectivity over diester formation. Mechanistic studies suggest that this selectivity originates from a shielding effect, where LiCl interacts with one terminal carboxylic acid group.


Introduction

Long-chain dicarboxylic fatty acids (LCDFAs) serve as critically important segments in drug molecules, facilitating specific electrostatic interactions between their terminal carboxylate anions and positively charged amino acid residues.1 Semaglutide, the first LCDFA-containing therapeutic approved by the FDA (2017), incorporates octadecanedioic acid 1 (Fig. 1). Marketed as Ozempic®, Wegovy®, and Rybelsus®, it generated a cumulative sales of USD 27.98 billion in 2024.2 Tirzepatide (approved in 2022/2023 as Mounjaro® and Zepbound®) features an extended carbon chain that enhances albumin binding,3 and it achieved sales of USD 16.47 billion in 2024. As LCDFA-based therapeutics advance,4 the highly selective synthesis of mono-protected LCDFAs improve the selectivity and reduce the costs during LCDFA segment incorporation.5 However, the synthesis of mono-protected LCDFAs is still a persistent challenge.6 To get these mono-protected LCDFAs, stoichiometric control of alcohols/activating reagents remains compromised by unavoidable diester formation.7 Current methods predominantly rely on ring-opening of intramolecular anhydride intermediates with alcohols—effective for C5–C7 chains8 but suffering from low yields in larger rings (Fig. 2a). Only few strategies directly achieve monoester selectivity over diesters by distinguishing the dicarboxylic acids using a heterogeneous strategy (Fig. 2b). Early heterogeneous approaches adsorbed diacids [HO2C(CH2)nCO2H; n = 3–8 and 10] on alumina, followed by monomethyl esterification with diazomethane/dimethyl sulfate.9 Phase-transfer catalysis enabled selective esterification of shorter diacids (n ≤ 12) with alkyl halides.10 Ion-exchange resins catalyzed transesterification to mono alkyl esters (n ≤ 12).11 Consequently, direct mono-selective synthesis, particularly of mono-tert-butyl esters from LCDFAs (n > 12), remains an unmet challenge.
image file: d5ra04970a-f1.tif
Fig. 1 Retrosynthetic analysis of the semaglutide's side chain and the key role of mono-tert-butyl ester.

image file: d5ra04970a-f2.tif
Fig. 2 Comparison of classic esterification methodologies and our strategy for constructing mono-protected esters. (a) Classical method by using the intramolecular anhydride intermediate; (b) other few successful strategies from heterogeneous system; (c) our strategy to differentiate the diacids.

To address this challenge, we analyzed long-chain alkyl diacids as structures featuring two terminal hydrophilic carboxylic acid groups connected by a hydrophobic carbon backbone.12 These carboxylic acid groups exhibited inherent affinity for metal cations via ionic or coordination bonding.13 Functionalization of one terminal carboxylate from a hydrophilic to a hydrophobic moiety maintained the inherent reverse micellar properties,14 including the self-assembly competence and compartmentalization behaviour. Concurrently, intermolecular chain–chain interactions occurred between the hydrophobic segments15 while partially shielding the metal-coordinated site, leaving a pre-activated esterification site (Fig. 2c). Building on classical esterification approaches,16 we identified LiCl as a crucial reagent, achieving monoester[thin space (1/6-em)]:[thin space (1/6-em)]diester selectivity up to 50[thin space (1/6-em)]:[thin space (1/6-em)]1. Our strategy involved: (a) lithium cation cluster formation with one carboxylic group through coordinative interactions; (b) exposure and activation of the distal carboxylic acid; and (c) selective mono-esterification even with excess reagents. A key observation confirmed this assembly behaviour: octadecanedioic acid 1 solubility in THF was significantly increased upon LiCl addition, yielding a clear mixture after the introduction of trifluoroacetic anhydride (TFAA) (Fig. S1). Conversely, reactions without LiCl produced cloudy suspensions.

Results and discussion

Initial assessment confirmed TFAA's reactivity in diester formation from octadecanedioic acid 1; reacting 2.4 equiv. t-BuOH with TFAA afforded diester 2a′ in 99% yield (Table 1, entry 13). Strikingly, introducing 1.0 equiv. LiCl reduced diacid conversion to 94% while achieving 7[thin space (1/6-em)]:[thin space (1/6-em)]1 mono/di selectivity (2a[thin space (1/6-em)]:[thin space (1/6-em)]2a′) (entry 12). Optimization revealed that 1.5 equiv. LiCl with 1.6 equiv. t-BuOH delivered dramatically improved selectivity (50[thin space (1/6-em)]:[thin space (1/6-em)]1, 2a[thin space (1/6-em)]:[thin space (1/6-em)]2a′) and 79% isolated yield of monoester 2a (entry 1). Other well-known Lewis acids were also evaluated based on the optimized conditions.17 Among these, AlCl3 afforded high conversion but generated multiple side products, and MgCl2 provided marginal enhancement in monoester selectivity (entries 2 and 3). These data suggested that the Lewis acidity of LiCl might not be the major contributor in supporting mono-esterification. On the other hand, the influence of various lithium salts was investigated. Lithium bromide (LiBr) significantly suppressed the reactivity, resulting in a low monoester conversion. Lithium carbonate (Li2CO3) afforded the desired product, albeit in a moderate yield and a monoester-to-diester selectivity ratio of 3[thin space (1/6-em)]:[thin space (1/6-em)]1. In contrast, lithium hydroxide monohydrate (LiOH·H2O) largely inhibited ester formation even though we fully dried the THF solution of LiOH·H2O and substrate 1 under high vacuum, followed by refilling of new anhydrous THF. These results established that the chloride anion is essential for selective monoester formation, which takes part in the key intermediate formation (entries 4–6). Studies on reaction robustness showed that elevated temperatures promoted THF-derived byproducts,18 but alternative solvents compromised monoester yields (entries 7–10). However, extended reaction time (48 h) had negligible impact on the yield with decreased mono/di selectivity (entry 14 compared with entry 1, 18[thin space (1/6-em)]:[thin space (1/6-em)]1 to 50[thin space (1/6-em)]:[thin space (1/6-em)]1). Last but not the least, scale-up using 100 g of 1 under optimized conditions provided 71% isolated yield of 2a without large selectivity compromise.
Table 1 Optimization of reaction parametersa

image file: d5ra04970a-u1.tif

Entry Salt (equiv.) tBuOH (equiv.) Solvent Time (h) Yield 2ab 2a[thin space (1/6-em)]:[thin space (1/6-em)]2a′c
a Experimental conditions: 1 (2 mmol), TFAA (4.8 mmol), t-BuOH (3.2 mmol), salts (3.0 mmol) in solvent (10 mL) at 25 °C for 24 h (entry 1); trace means only trace amount of product was detected; ND means no product was detected.b Isolated yield after column purification, data in parentheses indicate the conversion of compound 1.c Selectivity of 2a[thin space (1/6-em)]:[thin space (1/6-em)]2a′ was determined via HPLC-ELSD.d The reported yield data corresponded to a 100-gram scale reaction.e The isolated yield is the product of 2a′.
1 LiCl (1.5 equiv.) 1.6 THF 24 79 (92) 50[thin space (1/6-em)]:[thin space (1/6-em)]1
71 (84)d 35[thin space (1/6-em)]:[thin space (1/6-em)]1
2 AlCl3 (1.5 equiv.) 1.6 THF 24 26 (84) 1[thin space (1/6-em)]:[thin space (1/6-em)]2
3 MgCl2 (1.5 equiv.) 1.6 THF 24 48 (82) 2[thin space (1/6-em)]:[thin space (1/6-em)]1
4 LiBr (1.5 equiv.) 1.6 THF 24 3 (4) >99[thin space (1/6-em)]:[thin space (1/6-em)]1
5 Li2CO3 (0.75 equiv.) 1.6 THF 24 78 (50) 3[thin space (1/6-em)]:[thin space (1/6-em)]1
6 LiOH·H2O (1.5 equiv.) 1.6 THF 24 Trace
7 LiCl (1.5 equiv.) 1.6 MTBE 24 48 (55) 18[thin space (1/6-em)]:[thin space (1/6-em)]1
8 LiCl (1.5 equiv.) 1.6 2-Me-THF 24 Trace
9 LiCl (1.5 equiv.) 1.6 DCM 24 ND
10 LiCl (1.5 equiv.) 1.6 Toluene 24 ND
11 LiCl (1.5 equiv.) 1.6 THF 24 11 (19) >99[thin space (1/6-em)]:[thin space (1/6-em)]1
12 LiCl (1.0 equiv.) 2.4 THF 24 80 (94) 7[thin space (1/6-em)]:[thin space (1/6-em)]1
13 No LiCl 2.4 THF 24 >99e <1[thin space (1/6-em)]:[thin space (1/6-em)]99
14 LiCl (1.5 equiv.) 1.6 THF 48 73 (93) 18[thin space (1/6-em)]:[thin space (1/6-em)]1


The optimized protocol was first evaluated with alternative alcohols (methanol, isopropanol, and benzyl alcohol), affording good-to-excellent monoester selectivity despite significantly reduced conversions. Steric analysis revealed enhanced selectivity with bulkier alcohols (mono/di ratio: 2a > 4a > 3a; Fig. 3). Extension to diverse LCDFAs demonstrated broad substrate tolerance, delivering monoesters in moderate-to-good yields. Notably, the tirzepatide intermediate 7a was synthesized with 84% yield and 24[thin space (1/6-em)]:[thin space (1/6-em)]1 monoester/diester selectivity. The critical role of LiCl is evidenced by the predominant diester formation in its absence, even with stoichiometric alcohol, except for compounds 3a and 5a, which maintained monoester preference despite reduced selectivity. Limitations were also observed: unsaturated analogs with internal alkenes (8a, 9a; semaglutide/tirzepatide precursors) required elevated temperatures due to low reactivity; shorter chain dioic acids (dodecanedioic acid 10, malonic acid 11, and 1,4-cyclohexanedicarboxylic acid 12) yielded trace monoester; and terephthalic acid (13) showed no conversion under standard or harsher conditions.


image file: d5ra04970a-f3.tif
Fig. 3 Substrate scope of alcohols and dioic acids. Reaction conditions: substrate (2 mmol), TFAA (4.8 mmol), alcohol (3.2 mmol), LiCl (3.0 mmol) in THF (10 mL) at 25 °C for 24 h. Yield of the pure monoester product isolated by column chromatography. Monoester/diester ratio was determined via HPLC-ELSD analysis. Trace means trace amount of product was detected via HPLC-ELSD. NR equals no reaction. aReaction's temperature was 50 °C.

To illustrate the role of LiCl in this methodology, control experiments were conducted. Upon the addition of LiCl (0.04 mg mL−1, 1.0 mM) to a solution of octadecanedioic acid 1 (0.2 mg mL−1, 0.75 mM), the characteristic transition exhibited a significant hyperchromic shift in the UV spectrum (Fig. 4a), with the π → π* transition occurring at λ = 212 nm (Δε = 0.02 M−1 cm−1). This spectral modification demonstrated specific interactions between 1 and LiCl, consistent with the observed enhancement in solubility. Reversing the addition sequence from the standard protocol—introducing TFAA prior to LiCl—significantly reduced chemoselectivity (mono[thin space (1/6-em)]:[thin space (1/6-em)]di = 8[thin space (1/6-em)]:[thin space (1/6-em)]1 vs. 50[thin space (1/6-em)]:[thin space (1/6-em)]1; Fig. 4b). Nevertheless, this modified sequence still enabled monoester formation, suggesting that the LiCl would also interact with the bis(trifluoroacetyl) symmetrical anhydride intermediate 14 (structural formula: CF3C(O)–O–C(O)–CH2–(CH2)14–CH2–C(O)–O–C(O)CF3), facilitating its conversion to the corresponding monoester. The effect of LiCl was also evaluated; in particular, while a higher LiCl loading (>1.2 equiv.) improved the mono:di selectivity to >40[thin space (1/6-em)]:[thin space (1/6-em)]1, overstoichiometric amounts decreased the conversion (Fig. 4c). This inverse correlation further indicated that excess LiCl promotes decomposition of 14 to the unreactive carboxylic acid derivative, which failed to undergo esterification under these conditions.


image file: d5ra04970a-f4.tif
Fig. 4 Effect of LiCl on reactions. (a) UV absorption effect of LiCl in THF solution of compound 1; (b) the addition sequence effect of TFAA and LiCl; (c) the amount effect of LiCl on the selectivity 2a[thin space (1/6-em)]:[thin space (1/6-em)]2a’.

To gain further insights, 1H NMR (THF-d8) was performed, and it revealed an LiCl–1 interaction, with a distinctive new signal (δ 2.83 ppm) at the α-methylene group adjacent to the carbonyl group, emerging upon TFAA addition, which was distinct from those of 14 (δ 2.67 ppm) and free carboxylic acid 1 (δ 2.15 ppm) (Fig. 5a, S2 and S3 in SI).19 The crude reaction mixture was characterized by ESI-MS, which detected the mono-activated species 15 (structural formula: LiCl·HO–CO–CH2–(CH2)14–CH2–CO–O–COCF3) as [TFA–1 + H]+ (calcd m/z 411.2, found 411.3) prior to alcohol addition (Fig. 5b), confirming single-carboxyl activation in the absence of the bis-activated intermediate 14. On the other hand, complementary 19F NMR experiments in THF were carried out to monitor the reaction intermediates, given that all the activated species contained trifluoromethyl reporter groups. Fluorobenzene (δ −114.0 ppm in THF) was used as an internal reference. Commercial reagents were first characterized: trifluoroacetic anhydride (TFAA, δ −76.3 ppm), trifluoroacetic acid (TFAH, δ −76.7 ppm), and methyl trifluoroacetate (δ −75.9 ppm) (Fig. S4–S6 in SI). Next, a mixture of TFAA (2.4 mmol) and LiCl (1.5 mmol) in THF (5 mL) was analyzed (Fig. 5c). After stirring for 30 min, 19F NMR revealed a near-complete consumption of TFAA (δ −76.3 ppm) and a dominant new peak at δ −76.7 ppm. This species was observed for a prolonged reaction time (up to 3 hours). To identify the intermediate, methanol (5 equiv.) was added as a trapping agent, yielding methyl trifluoroacetate (δ −75.9 ppm) as an exclusive product. These observations confirmed that LiCl promoted TFAA disproportionation: CF3C(O)–O–C(O)CF3 + LiCl → CF3COOLi + CF3COCl.20 The resulting lithium trifluoroacetate (CF3COOLi) and trifluoroacetyl chloride (CF3COCl) displayed coincident 19F NMR resonances near δ −76.6 ppm (Fig. 5c), overlapping with the signal of trifluoroacetic acid (δ −76.7 ppm) and appearing as a single combined peak. Under these optimized conditions, 19F NMR analysis revealed a single coalesced signal at δ −76.6 ppm (Fig. 5d) following TFAA addition (0.5 h), which was distinct from the free TFAA (δ −76.3 ppm) and identical to the characteristic shift observed in the TFAA/LiCl pre-mixing system (Fig. 5c). This signal remained unchanged after extended stirring (3 h). Subsequent methanol addition (10 mmol, 5 equiv.) also yielded methyl trifluoroacetate (4.0% from all 19F integrations; δ −75.9 ppm) within 1 h, and with prolonged stirring, (18 h) the concentration increased to 27.2%. Combined with results for product 3a, the signal at δ −76.6 ppm was assigned to overlapping resonances from both 15 and trifluoroacetyl chloride—the latter was identified as the key byproduct under these conditions.


image file: d5ra04970a-f5.tif
Fig. 5 Spectroscopic mechanistic studies (NMR/MS), and reactivity comparison with inactive substrate. (a) 1H NMR studies of reaction process for active substrate 1; (b) ESI-MS experiment for mono-activation intermediate; (c) 19F NMR studies for LiCl effect on TFAA in THF; (d) 19F NMR studies for active substrate 1; (e) 19F NMR studies for adding the TFAA prior to LiCl; (f) 1H NMR studies for inactive substrate 10 under the optimized condition.

To check the effect of addition sequence of LiCl, 1H NMR (THF-d8) spectra were evaluated, which supported that the addition of LiCl to 14 could induce disproportionation (δ 2.67 to 2.83 ppm; Fig. S2, from spectrum E to spectrum F), giving the same mono-activated species 15. In 19F NMR studies, upon addition of TFAA to a THF solution of 1, two distinct 19F signals around δ −76.7 ppm emerged (Fig. 5e) in the absence of residual TFAA. The downfield signal was unequivocally assigned to 14. Subsequent introduction of LiCl induced complete signal conversion to a single peak (δ −76.6 ppm), identical to the spectrum obtained when LiCl was pre-mixed with TFAA (Fig. 5c). Crucially, methanol quenching experiments also yielded methyl trifluoroacetate (δ −75.9 ppm). This confirmed the capacity of LiCl to react with intermediate 14, which was consistent with salt metathesis, R–C(O)O–C(O)CF3 + LiCl → R–COOLi + CF3COCl, generating trifluoroacetyl chloride and mono-activated species 15. In parallel, the reaction of dodecanedioic acid 10—which yielded only a trace amount of mono-tert-butyl ester—was monitored by 1H NMR (THF-d8) under optimized conditions (Fig. 5f). Only a minor fraction of compound 10 was converted into a new species, characterized by a resonance at δ 2.83 ppm in the 1H NMR spectrum, while the majority of the substrate remained unreacted. Crucially, no signal corresponding to a trifluoroacetyl mixed anhydride intermediate (such as structure 14, which displayed a characteristic signal at δ 2.67 ppm) was observed. These results indicated that shorter-chain dicarboxylic acids (n ≤ 10) were unable to form the supramolecular assembly required to effectively sequester the chloride anion. Consequently, this inability led to an uncontrolled degradation of TFAA in the presence of LiCl, thereby inhibiting the ester formation.

Collectively, these studies demonstrated that LiCl promoted trifluoroacetyl mixed anhydride and TFAA decomposition via nucleophilic attack at the trifluoroacetyl moiety, forming the required intermediates and trifluoroacetyl chloride. This pathway aligned well with the experimental observations, wherein LiCl (i) reduced the reaction conversion (Fig. 4c) and (ii) completely suppressed the esterification of short-chain fatty diacids (C3–C12, Fig. 3). For long-chain dicarboxylic acids (n ≥ 14), hydrophobic encapsulation and steric shielding attenuated chloride's nucleophilic accessibility, significantly reducing the decomposition pathways while maintaining the catalytic cyclization efficacy.

The following mechanistic proposal highlighting the role of LiCl was given: (a) Li+ coordinates with one carboxylic acid; (b) hydrophobic chain packing partially exposes the distal carboxylic acid and hides the chloride; (c) the exposed site undergoes selective mono(trifluoroacetyl) mixed anhydride formation; and the (d) corresponding alcohol reacts with the mono(trifluoroacetyl) mixed anhydride to complete the mono-esterification of diacids (Fig. 6, path a). When a symmetrical bis(trifluoroacetyl) mixed anhydride intermediate is pre-formed, the LiCl in the system would attack the more electron deficient trifluoroacetyl group to disproportionate the bis(trifluoroacetyl) mixed anhydrides to mono-activated assemblies (Fig. 6, path b).


image file: d5ra04970a-f6.tif
Fig. 6 Mechanistic pathways to the key mono-esterification intermediate.

Conclusions

In summary, we developed a highly selective mono-esterification protocol for long-chain dicarboxylic fatty acids (LCDFAs; n ≥ 14), achieving unprecedented mono-/di-ester selectivity (up to 50[thin space (1/6-em)]:[thin space (1/6-em)]1). This method demonstrated excellent functional group tolerance across LCDFA substrates, with 100-gram scale synthesis confirming its industrial viability. Mechanistic studies established that the LiCl-mediated mono-carboxylate activation and selective mono(trifluoroacetyl) mixed anhydride formation drive the observed selectivity. This methodology enables large-scale production of key peptide therapeutic intermediates.

Author contributions

Y. Kuang and T. Qin discovered and developed the reaction. Y. Kuang, T. Qin and J. Wang performed the experiments. Y. Kuang, X. Yang, P. Guo and C. Jiang conceived and designed the investigation. Y. Kuang and C. Jiang wrote the manuscript.

Conflicts of interest

The authors declare no conflict of interest.

Data availability

Experimental procedures, characterization data and NMR spectra of the new compounds are included in the supplementary information (SI). Supplementary information is available. See DOI: https://doi.org/10.1039/d5ra04970a.

Acknowledgements

We appreciate Southwest Jiaotong University (Grant No. R113622H01064) and AstaTech (Chengdu) Biopharmaceutical Corporation for experimental and financial support. We also thank the AstaTech (Chengdu) Biopharmaceutical Corporation's Analytical & Testing Center for NMR and MS analysis.

Notes and references

  1. C. E. Callmann, C. L. M. LeGuyader, S. T. Burton, M. P. Thompson, R. Hennis, C. Barback, N. M. Henriksen, W. C. Chan, M. J. Jaremko, J. Yang, A. Garcia, M. D. Burkart, M. K. Gilson, J. D. Momper, P. A. Bertin and N. C. Gianneschi, J. Am. Chem. Soc., 2019, 141, 11765 CrossRef CAS PubMed.
  2. N. A. McGrath, M. Brichacek and J. T. Njardarson, J. Chem. Educ., 2010, 87, 1348 CrossRef CAS.
  3. J. Lau, P. Bloch, L. Schäffer, I. Pettersson, J. Spetzler, J. Kofoed, K. Madsen, L. B. Knudsen, J. McGuire, D. B. Steensgaard, H. M. Strauss, D. X. Gram, S. M. Knudsen, F. S. Nielsen, P. Thygesen, S. Reedtz-Runge and T. Kruse, J. Med. Chem., 2015, 58, 7370 CrossRef CAS PubMed.
  4. A. A. Bhattacharya, T. Grüne and S. Curry, J. Mol. Biol., 2000, 303, 721 CrossRef CAS PubMed.
  5. (a) N. S. Curvey, S. E. Luderer, J. K. Walker and G. W. Gokel, Synthesis, 2014, 46, 2771 CrossRef CAS; (b) X. Liu, N. Zhang, X. Gu, Y. Qin, D. Song, L. Zhang and S. Ma, ACS Comb. Sci., 2020, 22, 821 CrossRef CAS PubMed; (c) M. O. Frederick, R. A. Boyse, T. M. Braden, J. R. Calvin, B. M. Campbell, S. M. Changi, S. R. Coffin, C. Condon, O. Gowran, J. M. Groh, S. R. Groskreutz, Z. D. Harms, A. A. Humenik, N. J. Kallman, N. D. Klitzing, M. E. Kopach, J. K. Kretsinger, G. R. Lambertus, J. T. Lampert, L. M. Maguire, H. A. Moynihan, N. S. Mullane, J. D. Murphy, M. E. O'Mahony, R. N. Richey, K. D. Seibert, R. D. Spencer, M. A. Strege, N. Tandogan, F. L. Torres Torres, S. V. Tsukanov and H. Xia, Org. Process Res. Dev., 2021, 25, 1628 CrossRef CAS.
  6. (a) X. X. Zhang, C. A. H. Prata, J. A. Berlin, T. J. McIntosh, P. Barthelemy and M. W. Grinstaff, Bioconjugate Chem., 2011, 22, 690 CrossRef CAS PubMed; (b) V. Santacroce, F. Bigi, A. Casnati, R. Maggi, L. Storaro, E. Moretti, L. Vaccaro and G. Maestri, Green Chem., 2016, 18, 5764 RSC.
  7. N. Jain, Y. Arntz, V. Goldschmidt, G. Duportail, Y. Mély and A. S. Klymchenko, Bioconjugate Chem., 2010, 21, 2110 CrossRef CAS PubMed.
  8. Selected examples: (a) J. Poldy, R. Peakall and R. A. Barrow, Tetrahedron Lett., 2008, 49, 2446 CrossRef CAS; (b) R. Geyer, U. Nordemann, A. Strasser, H. Wittmann and A. Buschauer, J. Med. Chem., 2016, 59, 3452 CrossRef CAS PubMed; (c) C. Beato, C. Pecchini, C. Cocconcelli, B. Campanini, M. Marchetti, M. Pieroni, A. Mozzarelli and G. Costantino, J. Enzyme Inhib. Med. Chem., 2016, 31, 645 CrossRef CAS PubMed; (d) Y. Gao, M. J. Haren, E. E. Moret, J. J. M. Rood, D. Sartini, A. Salvucci, M. Emanuelli, P. Craveur, N. Babault, J. Jin and N. I. Martin, J. Med. Chem., 2019, 62, 6597 CrossRef CAS PubMed.
  9. H. Ogawa, T. Chihara and K. Taya, J. Am. Chem. Soc., 1985, 107, 1365 CrossRef CAS.
  10. J. D. L. Zerda, G. Barak and Y. Sasson, Tetrahedron, 1989, 45, 1533 CrossRef.
  11. M. Saitoh, S. Fujisaki, Y. Ishii and T. Nishiguchi, Tetrahedron Lett., 1996, 37, 6733 CrossRef CAS.
  12. F. R. Taylor, D. Wen, E. A. Garber, A. N. Carmillo, D. P. Baker, R. M. Arduini, K. P. Williams, P. H. Weinreb, P. Rayhorn, X. Hronowski, A. Whitty, E. S. Day, A. Boriack-Sjodin, R. I. Shapiro, A. Galdes and R. Blake Pepinsky, Biochemistry, 2001, 40, 4359 CrossRef CAS PubMed.
  13. (a) G. Murdachaew, M. Valiev, S. M. Kathmann and X. Wang, J. Phys. Chem. A, 2012, 116, 2055 CrossRef CAS PubMed; (b) A. Sthoer, J. Hladílková, M. Lund and E. Tyrode, Phys. Chem. Chem. Phys., 2019, 21, 11329 RSC.
  14. N. M. Correa, J. J. Silber, R. E. Riter and N. E. Levinger, Chem. Rev., 2012, 112, 4569 CrossRef CAS PubMed.
  15. P. B. Miranda, V. Pflumio, H. Saijo and Y. R. Shen, J. Am. Chem. Soc., 1998, 120, 12092 CrossRef CAS.
  16. (a) M. Stacey, E. J. Bourne, J. C. Tatlow and J. M. Tedder, Nature, 1949, 164, 705 CrossRef CAS PubMed; (b) A. K. Chakraborti and R. Gulhane, Tetrahedron Lett., 2003, 44, 6749 CrossRef CAS.
  17. The LiCl was also widely used as Lewis acid, selected examples: (a) S. Bera, R. C. Samanta, C. G. Daniliuc and A. Studer, Angew. Chem., Int. Ed., 2014, 53, 9622 CrossRef CAS PubMed; (b) M. V. Marques and M. M. Sá, J. Org. Chem., 2014, 79, 4650 CrossRef CAS PubMed; (c) Y. Reddi and R. B. Sunoj, ACS Catal., 2017, 7, 530 CrossRef CAS.
  18. M. Y. Bhat, A. H. Padder, R. Gupta and Q. N. Ahmed, J. Org. Chem., 2023, 88, 14323 CrossRef CAS PubMed.
  19. For more information, see SI.
  20. Selected similar examples: (a) J. Heliński, Z. Skrzypczyński, J. Wasiak and J. Michalski, Phosphorus, Sulfur, Silicon Relat. Elem., 1990, 54, 225 CrossRef; (b) O. V. Kupriyanova, V. A. Shevyrin, Y. M. Shafran, A. T. Lebedev, V. A. Milyukov and V. L. Rusinov, Drug Test. Anal., 2020, 12, 1154 CrossRef CAS PubMed; (c) A. F. C. Flores, P. F. Rosales, J. L. Malavolta and D. C. Flores, J. Braz. Chem. Soc., 2024, 25, 1439 Search PubMed.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.